glutathione pathway to triple negative cancer

glutathione pathway to triple negative cancer Ferroptosis heterogeneity in triple-negative breast reveals an innovative immunotherapy combination strategy Activation of the eIF2α/ATF4 axis

Name: glutathione pathway to triple negative cancer Ferroptosis heterogeneity in triple-negative breast reveals an innovative immunotherapy combination strategy Activation of the eIF2α/ATF4 axis
Brand: equiscorp.hu
SKU: 53510204845
Price: 21.81 USD
Availability: InStock
Rating: 4.3699 (14 reviews)

Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression ScienceDirect Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy Lv 2019 Oxidative Medicine and Cellular Longevity Wiley Online Library

SKU: 53510204845 · From equiscorp.hu

4.4

USD21.81 USD70.81

Pay in 4 interest-free payments of $5.45 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

Pesticide exposure and self-reported Parkinsons disease in the agricultural health study

IGF1-LR3, thanks to its long half-life, is highly effective in counteracting myostatin and appears to work by activating a muscle protein called MyoD [1], [2]